Florida Cancer Specialists Press Release
Florida Blue and Florida Cancer Specialists Introduce Accountable Cancer Provider Program
Fort Myers, FL – November 11, 2016……… Florida Blue, Florida’s Blue Cross and Blue Shield company, and Florida Cancer Specialists & Research Institute (FCS), the leading community oncology/hematology practice in the state, are proud to announce a new agreement implementing an accountable provider program specific to the treatment of cancer. This program supports the highest quality and more coordinated patient-centered cancer care.
Cancer is one of the most common and devastating diseases in the United States. According to the National Institutes of Health (NIH), more than 1.6 million new cases of cancer will be diagnosed in 2016, and an estimated 600,000 Americans will die from the disease. Based on growth and aging of the U.S. population, NIH projects that, in the year 2020, medical expenditures for cancer will reach at least $158 billion (in 2010 dollars)— an increase of 27 percent over 2010.
An accountable provider program is an important step in moving away from the traditional payment model that focuses on fee for service to a payment model that creates value and a holistic approach to member care. Under this type of shared savings program, Florida Blue collaborates with Florida Cancer Specialists and its network of health care providers, sharing in the medical and financial responsibility for a group of patients. The overall goals of accountable provider arrangements are to improve the individual patient care experience and overall health, as well as decrease medical costs. The shared savings program benefits patients in more than 20 counties across Florida, providing data sharing and care coordination focused on both high quality and cost efficiencies.
“Florida Blue continues to launch innovative new programs across the state designed to improve member care while keeping medical costs down,” said Kirk Fischer, Florida Blue vice president of Delivery System. “Our accountable provider program with Florida Cancer Specialists will allow us to collaborate in order to provide a better care experience for our members when facing an intimidating cancer diagnosis.”
"We are pleased to team up with Florida Blue on this new initiative,” said Florida Cancer Specialists CEO Bradley Prechtl “This partnership focuses on the value we provide to our patients. Ensuring clinically excellent, compassionate and cost-effective care in a community setting is at the heart of our mission.”
Dr. William Harwin, Founder and President of Florida Cancer Specialists, said, “Our collaboration with Florida Blue supports our commitment to provide high quality, cost effective oncology care. With the increasing cost of cancer care, we have a responsibility to partner with Florida Blue to help manage and better control the cost of care while maintaining quality metrics. FCS has the infrastructure, support team and physician leaders to make this a reality.”
Florida Cancer Specialists & Research Institute offers a full range of oncology and hematology services, including clinical research and the use of evidence-based medicine and proactive patient support services. FCS is a strategic site of the Sarah Cannon Research Institute, one of the largest community-based clinical trial organizations in the United States.
About Florida Blue
Florida Blue, Florida’s Blue Cross and Blue Shield Company, is a leader in Florida’s health care industry. Driven by its mission to help people and communities achieve better health, Florida Blue serves approximately 5 million members across the state. An additional 15.5 million people in 16 states are served through its affiliated companies. Florida Blue is a not-for-profit, policyholder-owned, tax-paying mutual company. Headquartered in Jacksonville, Fla., it is an independent licensee of the Blue Cross and Blue Shield Association, an association of independent Blue Cross and Blue Shield companies. For more information, visit FloridaBlue.com
About Florida Cancer Specialists & Research Institute: (FLCancer.com)
Founded in 1984, Florida Cancer Specialists & Research Institute (FCS) is the largest independent medical oncology/hematology practice in the United States. With over 200 physicians, 150 nurse practitioners and physician assistants and over 90 locations in our network, we are committed to providing world-class cancer care in community-based settings close to home.
Recognized by the American Society of Clinical Oncology (ASCO) with a national Clinical Trials Participation Award, FCS offers patients access to more clinical trials than any private oncology practice in Florida. 70% of new cancer drugs approved in 2015 for use in the U.S. were studied in clinical trials conducted with FCS participation*. Our physicians are consistently ranked nationally as Top Doctors by U.S. News & World Report. Trained in such prestigious medical schools and research institutes as Duke, Stanford, Harvard, Emory, M.D. Anderson, and Memorial Sloan-Kettering, the physicians of Florida Cancer Specialists provide leadership and consultation in the state's leading hospitals.
FCS serves patients on the Gulf Coast from Naples to the greater Tampa Bay area, north as far as Tallahassee, in Orlando and surrounding Central Florida communities, and on the East Coast in Daytona/Palm Coast, Vero Beach/Sebastian and in Palm Beach County.
Florida Cancer Specialists has built a national reputation for excellence that is reflected in exceptional and compassionate patient care, driven by innovative clinical research and cutting-edge technologies that help advance targeted treatments and genetically-based immunotherapies, and embodied by our outstanding team of highly-trained and dedicated physicians, clinicians and staff.
* Prior to approval
For More Information, Contact:
Florida Cancer Specialists Foundation & Research Institute
Shelly Glenn, Chief Marketing & Sales Officer -
Chris Wilkerson -
813.281.0088 ext. 315
Ganick Communications, Inc.
Elaine Ganick -